Difficulty: Medium
Average Score: 88%
Practice
A 58-year-old man undergoes open-heart surgery for a triple coronary artery bypass graft. His surgery goes smoothly, but the next day he develops chest palpitations. Metoprolol is started to keep his supraventricular tachycardia from interfering with ventricular rhythm. Under which Singh-Vaughan Williams class of antiarrhythmics does metoprolol fall?
Correct answer
D
Rationale
Metoprolol falls under Class II of the Singh-Vaughan Williams antiarrhythmic classification system. Class II antiarrhythmics are beta-blockers that primarily target beta-adrenergic receptors in the heart, specifically beta-1 receptors. By blocking these receptors, metoprolol reduces sympathetic stimulation to the heart, leading to decreased heart rate, contractility, and conduction velocity. In the case of the patient post-coronary artery bypass graft, metoprolol is used to control supraventricular tachycardia, a condition where the heart's electrical signals are originating above the ventricles.
Option A (Class Ia) includes drugs like quinidine and procainamide, which act by blocking sodium channels to slow impulse conduction. These drugs are more commonly used for ventricular arrhythmias rather than supraventricular tachycardia.
Option B (Class Ib) consists of drugs like lidocaine and mexiletine, which also block sodium channels but are more effective for ventricular arrhythmias rather than supraventricular tachycardia.
Option C (Class Ic) includes drugs like flecainide and propafenone, which are potent sodium channel blockers used for ventricular arrhythmias or atrial fibrillation/flutter, not supraventricular tachycardia like in this case.
In an educational context, understanding the classification of antiarrhythmic drugs is crucial for healthcare professionals to make informed decisions about the appropriate management of arrhythmias. By knowing the mechanism of action of each class, providers can tailor treatment to specific arrhythmia types and patient conditions, ensuring optimal outcomes and minimizing potential adverse effects.
Option A (Class Ia) includes drugs like quinidine and procainamide, which act by blocking sodium channels to slow impulse conduction. These drugs are more commonly used for ventricular arrhythmias rather than supraventricular tachycardia.
Option B (Class Ib) consists of drugs like lidocaine and mexiletine, which also block sodium channels but are more effective for ventricular arrhythmias rather than supraventricular tachycardia.
Option C (Class Ic) includes drugs like flecainide and propafenone, which are potent sodium channel blockers used for ventricular arrhythmias or atrial fibrillation/flutter, not supraventricular tachycardia like in this case.
In an educational context, understanding the classification of antiarrhythmic drugs is crucial for healthcare professionals to make informed decisions about the appropriate management of arrhythmias. By knowing the mechanism of action of each class, providers can tailor treatment to specific arrhythmia types and patient conditions, ensuring optimal outcomes and minimizing potential adverse effects.